The Market's Island of Misfit Toys: Who Is Actually Making Cash in 2026?Global Report·18 hours agoFSHPR-0.11%ADPT-0.18%
Tech and Biotech Overhauls Accelerate Amid 50% Revenue SurgesGlobal Report·18 hours agoTKR+0.29%RADX-17.25%
Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 millionPUBT·Jul 23 at 06:35 PMADPT-0.18%
This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesdaybenzinga_article·Jul 21 at 10:14 AMFTNT+0.55%GS-C+7.00%
Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000PUBT·Jul 20 at 06:20 PMADPT-0.18%
Is Adaptive Biotechnologies (ADPT) Below Fair Value Or Too Pricey On Sales?Simplywall·Jul 17 at 08:06 PMADPT-0.18%
Adaptive Biotechnologies Chief People Officer Francis Lo disposes of 105,762 common shares worth $2.39 millionPUBT·Jul 17 at 06:24 PMADPT-0.18%
Adaptive Biotechnologies (ADPT) Stock Looks Reasonable On Cash Flow Yet Rich On SalesSimplywall·Jul 10 at 04:27 PMADPT-0.18%
Adaptive Biotechnologies to report Q2 2026 results after market close, host conference callPUBT·Jul 9 at 03:06 PMADPT-0.18%
Adaptive Biotech CSO Harlan S. Robins disposes of USD 8.49 million in common sharesPUBT·Jul 7 at 05:53 PMADPT-0.18%
Adaptive Biotechnologies CCO Susan Bobulsky sells 487 shares worth $10,714PUBT·Jul 6 at 06:16 PMADPT-0.18%
Adaptive Biotechnologies Chief Commercial Officer Imm Med Sharon Benzeno sells 165,802 shares for $3.73 millionPUBT·Jun 30 at 06:25 PMADPT-0.18%
Adaptive Biotechnologies director Michelle Renee Griffin disposes of 52,084 common shares worth $1,051,855.12PUBT·Jun 29 at 06:50 PMADPT-0.18%
Adaptive Biotechnologies (ADPT) Plans A Business Split, Is The Valuation Already Full?Simplywall·Jun 29 at 10:51 AMADPT-0.18%
